Genes for seeds arose early in plant evolution, ferns reveal
The emergence of seed-producing plants more than 300 million years ago was an evolutionary watershed, opening new environments to plants and ultimately leading to the flowering plants that brighten our world and supply much of our food. But it was less of a leap than it seems, newly published DNA sequences suggest.
The genomes, from three fern species and a cycad, one of the oldest kinds of seed-bearing plants, show genes key to making seeds are the same as those in the spore-producing machinery of ferns, which emerged tens of millions of years earlier. They evidently existed in a common ancestor but were recruited i...
Source: ScienceNOW - September 22, 2022 Category: Science Source Type: news
President Biden wants to build a 'bioeconomy.' Here's what that means for Boston.
"My view is that out-there stuff is Boston's strength," said Ginkgo Bioworks' Jason Kelly, who attended the White House's bioeconomy summit last week. "I think we should drive a truck through this. I think this is going to be a great opportunity for Boston." (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 20, 2022 Category: American Health Authors: Rowan Walrath Source Type: news
White House taps biotech executive to lead new federal biomedical agency
The Biden White House has selected an executive from Boston-based Ginkgo Bioworks as the first director of the Advanced Research Projects Agency for Health (ARPA-H) in what could be an encouraging sign for the industry leaders, advocates and politicians who have sought to establish the headquarters of the new federal biomedical agency in Boston.
Renee Wegrzyn, the vice president of business development at synthetic biology firm Ginkgo Bioworks Holdings Inc. (NYSE: DNA), is set to lead ARPA-H, the … (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 13, 2022 Category: Biotechnology Authors: Rowan Walrath Source Type: news
ChromaDex founder takes helm at Ginkgo Bioworks spinout
Just under a year after launching, a 'nutraceuticals' startup spun out of Ginkgo Bioworks Holdings Inc. has its first CEO. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 24, 2022 Category: American Health Authors: Rowan Walrath Source Type: news
What's behind those $381M executive paydays at Ginkgo Bioworks?
The company ’s top two executives also happen to be founders, leading to massive compensation packages for both last year. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 29, 2022 Category: Health Management Authors: Rowan Walrath Source Type: news
Ginkgo Bioworks acquires competitor for $300M
The synthetic biology firm Ginkgo Bioworks Holdings Inc. will acquire a California company in an all-stock transaction valued at $300 million. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 25, 2022 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news
Developer helps bring ‘BioBus’ to Boston with Ginkgo HQ project
Some real estate firms have proposed creating job-training spaces in the life sciences projects they're building. Marcus Partners wants to take that sort of training on the road. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 10, 2022 Category: Pharmaceuticals Authors: Greg Ryan Source Type: news
What the Science Says About the Health Benefits of Vitamins and Supplements
From multivitamins and melatonin to fiber and fish oil, Americans who are trying to boost their health and immunity have a plethora of supplements to choose from. An estimated 58% of U.S. adults ages 20 and over take dietary supplements, according to the U.S. Centers for Disease Control and Prevention, and the supplement industry is valued at more than $30 billion a year. Supplement use has been growing rapidly over the past few decades along with the wellness industry.
“The popular belief is that a supplement is going to be helpful for promoting health,” says Fang Fang Zhang, a professor at Tufts University&rs...
Source: TIME: Health - April 28, 2022 Category: Consumer Health News Authors: Sandeep Ravindran Tags: Uncategorized Diet & Nutrition healthscienceclimate Source Type: news
The Petri Dish: Flagship appoints new CEO-partners, Ginkgo partners on another spinout
Here's The Petri Dish, a roundup of news that may get overlooked amid the influx of health care happenings. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 14, 2022 Category: Health Management Authors: Rowan Walrath Source Type: news
Ginkgo Biloba
Title: Ginkgo BilobaCategory: MedicationsCreated: 3/15/2022 12:00:00 AMLast Editorial Review: 3/15/2022 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 15, 2022 Category: Drugs & Pharmacology Source Type: news
Ginkgo Bioworks, Broad Institute rush to aid in hunt for omicron in the U.S.
As health authorities race to figure out where the omicron variant of the coronavirus is spreading in the U.S., two local organizations are working to aid in the effort. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 3, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news
VC Firm 11.2 Capital Raises $101 Million To Back More ‘Deep Tech’ Companies Like Ginkgo Bioworks And Hinge Health
Las Vegas-based Shelley Zhuang was an early investor in Cruise, Ginkgo Bioworks and Hinge Health. Now she has $101,010,101 for a second "deep tech" fund. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 1, 2021 Category: Pharmaceuticals Authors: Alex Konrad, Forbes Staff Tags: Venture Capital /venture-capital Innovation /innovation Healthcare /healthcare Science /science Money /money Investing /investing Editors' Pick editors-pick technology Source Type: news
Spinout launches with $78M to bioengineer beauty products
After two years in the labs of Ginkgo Bioworks Holdings Inc. as an entrepreneur-in-residence, Jasmina Aganovic is striking out on her own as CEO of a new startup at the intersection of biotech and beauty: Arcaea.
Founded in March as Kalo Ingredients, Arcaea publicly launched Wednesday with a $78 million Series A round, placing it squarely among the largest Series A rounds this year among Massachusetts life sciences companies. Cascade Investment L.L.C., Viking Global, CHANEL, Givaudan and Wittington… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 29, 2021 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news
Ginkgo Bioworks rises on first day of NYSE debut
Ginkgo raised about $1.6 billion through its public offering. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 17, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news
Ginkgo Bioworks rises on first day of NYSE debut
Ginkgo raised about $1.6 billion through its public offering. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 17, 2021 Category: American Health Authors: Rowan Walrath Source Type: news
